CAS: 2320561-35-9
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
ERD-308 REF: TM-T13685CAS: 2320561-35-9 | 98% | 862.00 €~2,501.00 € | Tue 07 Jan 25 | |
ERD 308 REF: 3D-VSD56135CAS: 2320561-35-9 | Min. 95% | To inquire | Tue 18 Feb 25 |
ERD-308
CAS:2320561-35-9
ERD-308, potent at 5nM, achieves >95% ER degradation in ER+ breast cancer, with DC50 of …
Formula:
C55H65N5O9S2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
1004.26
Ref: TM-T13685
25mg | 862.00 € | ||
50mg | 1,557.00 € | ||
100mg | 2,501.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
ERD 308
CAS:2320561-35-9
ERD 308 is a small molecule that inhibits the proteasome-mediated degradation of proteins by inhibiting …
Formula:
C55H65N5O9S2
Purity:
Min. 95%
Molecular weight:
1,004.3 g/mol
Ref: 3D-VSD56135
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025